Telesis Bio (TBIO)
NASDAQ:TBIO
US Market
Holding TBIO?
Track your performance easily

Telesis Bio (TBIO) Financial Statements

120 Followers

Telesis Bio Financial Overview

Telesis Bio's market cap is currently ―. The company's EPS TTM is $-30.824; its P/E ratio is -0.05; Telesis Bio is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-5.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.55M$ 3.44M$ 5.56M$ 8.65M$ 6.32M
Gross Profit$ -799.00K$ 1.45M$ 3.00M$ 5.69M$ 3.51M
EBIT$ -11.35M$ -8.42M$ -9.93M$ -8.28M$ -10.87M
EBITDA$ -10.52M$ -7.22M$ -9.08M-$ -9.64M
Net Income Common Stockholders$ -13.18M$ -9.22M$ -11.20M$ -8.44M$ -11.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.21M$ 15.60M$ 41.45M$ 47.35M$ 23.53M
Total Assets$ 52.73M$ 63.33M$ 105.03M$ 114.53M$ 89.16M
Total Debt$ 35.55M$ 36.12M$ 49.92M$ 49.26M$ 50.43M
Net Debt$ 25.34M$ 20.52M$ 8.46M$ 1.91M$ 26.89M
Total Liabilities$ 73.26M$ 41.68M$ 58.54M$ 58.46M$ 52.54M
Stockholders Equity$ -20.55M$ -8.24M$ 17.77M$ 27.92M$ 36.62M
Cash Flow-
Free Cash Flow$ -5.43M$ -3.74M$ -5.98M-$ -11.65M
Operating Cash Flow$ -5.35M$ -3.24M$ -5.89M$ -10.30M$ -11.18M
Investing Cash Flow$ 1.13M$ 12.25M$ -23.21M$ 6.85M$ 4.12M
Financing Cash Flow$ -7.00K$ -27.00K$ -101.00K$ 26.70M$ -20.00K
Currency in USD

Telesis Bio Earnings and Revenue History

Telesis Bio Debt to Assets

Telesis Bio Cash Flow

Telesis Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis